Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 91451-91500 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05282745
A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL
N/A
Recruiting
4,000 participants
Started: Dec 15, 2021 · Completed: Dec 31, 2024
3 conditions
1 sponsor
10 locations
NCT04933149
Ketamine Infusion for Neuropathic Pain in Brachial Plexus Injuries
PHASE4
Enrolling by invitation
100 participants
Started: Dec 15, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05198245
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
N/A
Active, not recruiting
1 participants
Started: Dec 15, 2021 · Completed: Apr 17, 2028
1 condition
3 sponsors
1 location
NCT05154370
China National Registry of Neuro-Inflammatory Diseases
N/A
Recruiting
10,000 participants
Started: Dec 15, 2021 · Completed: Nov 1, 2026
7 conditions
1 sponsor
1 location
NCT04522622
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
PHASE4
Recruiting
48 participants
Started: Dec 15, 2021 · Completed: Sep 1, 2027
4 conditions
5 sponsors
4 locations
NCT05182385
Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Dec 15, 2021 · Completed: Apr 30, 2026
1 condition
2 sponsors
17 locations
NCT05033964
The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions
PHASE2
Active, not recruiting
200 participants
Started: Dec 15, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
14 locations
NCT05025293
Zoledronate Early to Hip Fracture Patients - Safe and Effective?
PHASE4
Recruiting
300 participants
Started: Dec 15, 2021 · Completed: Mar 31, 2026
2 conditions
4 sponsors
1 location
NCT04638725
Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer
N/A
Recruiting
9,000 participants
Started: Dec 15, 2021 · Completed: Dec 15, 2029
1 condition
1 sponsor
1 location
NCT05018208
Remote Monitoring in Cancer Care: A Platform Study
N/A
Active, not recruiting
100 participants
Started: Dec 15, 2021 · Completed: Sep 15, 2026
5 conditions
1 sponsor
1 location
NCT05041309
Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells
N/A
Enrolling by invitation
1,000 participants
Started: Dec 15, 2021 · Completed: Dec 31, 2040
1 condition
1 sponsor
87 locations
NCT05108896
Aspiration in Acute Respiratory Failure Survivors 2
NA
Recruiting
855 participants
Started: Dec 15, 2021 · Completed: Dec 15, 2025
2 conditions
2 sponsors
5 locations
NCT05162144
Proximal Medial Gastriocnemius Recession for Chronic Plantar Fasciitis
NA
Active, not recruiting
150 participants
Started: Dec 15, 2021 · Completed: Mar 15, 2026
1 condition
1 sponsor
1 location
NCT05133154
LIQUID BIOPSY IN Low-grade Glioma Patients
NA
Recruiting
50 participants
Started: Dec 15, 2021 · Completed: Jul 1, 2025
1 condition
1 sponsor
1 location
NCT05205174
Depth Electrode Detection of Cortical Spreading Depolarization After Traumatic Brain Injury
NA
Recruiting
15 participants
Started: Dec 15, 2021 · Completed: Jul 1, 2027
1 condition
1 sponsor
1 location
NCT04941287
Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer
PHASE2
Active, not recruiting
57 participants
Started: Dec 15, 2021 · Completed: Apr 29, 2026
10 conditions
1 sponsor
29 locations
NCT06219720
The Texas Interprofessional Pharmacogenomics (IPGx)
N/A
Recruiting
50 participants
Started: Dec 15, 2021 · Completed: Nov 30, 2027
1 condition
5 sponsors
1 location
NCT05116176
TRAjectories and CLinical ExpeRiences of ICD Therapy Study
N/A
Enrolling by invitation
500 participants
Started: Dec 15, 2021 · Completed: Mar 31, 2026
1 condition
7 sponsors
1 location
NCT05170334
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma
PHASE2
Active, not recruiting
7 participants
Started: Dec 15, 2021 · Completed: Jan 31, 2028
1 condition
3 sponsors
1 location
NCT05089162
CHF-COV Reduced (Chronic Heart Failure With Reduced Ejection Fraction - COngestion eValuation)
NA
Recruiting
200 participants
Started: Dec 14, 2021 · Completed: Jun 14, 2029
2 conditions
1 sponsor
1 location
NCT05328167
Contrast-Enhanced Ultrasound for the Prediction of Bile Duct Cancer Response to Radioembolization Treatment
PHASE2
Recruiting
20 participants
Started: Dec 14, 2021 · Completed: Jul 31, 2025
1 condition
2 sponsors
1 location
NCT05111210
Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis
N/A
Recruiting
90 participants
Started: Dec 14, 2021 · Completed: Jun 30, 2028
1 condition
2 sponsors
1 location
NCT05089149
Chronic Heart Failure - COngestion eValuation
NA
Recruiting
200 participants
Started: Dec 14, 2021 · Completed: Jun 14, 2029
1 condition
1 sponsor
2 locations
NCT05100095
Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
PHASE2
Recruiting
52 participants
Started: Dec 14, 2021 · Completed: Sep 1, 2028
1 condition
1 sponsor
1 location
NCT05195775
Tadalafil as Adjuvant Therapy for DMD
PHASE2/PHASE3
Active, not recruiting
25 participants
Started: Dec 14, 2021 · Completed: Sep 5, 2025
1 condition
1 sponsor
1 location
NCT06316791
Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases
EARLY_PHASE1
Recruiting
24 participants
Started: Dec 14, 2021 · Completed: Dec 13, 2025
1 condition
1 sponsor
1 location
NCT06329739
Genetics in Parkinson's Disease: Behavioral and Cognitive Outcomes
N/A
Recruiting
68 participants
Started: Dec 14, 2021 · Completed: Dec 14, 2031
1 condition
1 sponsor
1 location
NCT05157672
Evaluating the Pharmacokinetics and Drug Interaction Potential of the Botanical Dietary Supplement Cinnamon
EARLY_PHASE1
Active, not recruiting
16 participants
Started: Dec 14, 2021 · Completed: Aug 31, 2024
1 condition
3 sponsors
1 location
NCT04843683
StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias (START-CA)
NA
Recruiting
60 participants
Started: Dec 14, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04685070
Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer
PHASE2
Active, not recruiting
56 participants
Started: Dec 14, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04998786
"A Multi-center Open-label Phase 2 Study of Ixazomib, Iberdomide and Dexamethasone in Elderly Patients With Multiple Myeloma at First Relapse."
PHASE2
Active, not recruiting
75 participants
Started: Dec 14, 2021 · Completed: Jan 1, 2030
1 condition
1 sponsor
21 locations
NCT04996017
Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
PHASE3
Recruiting
162 participants
Started: Dec 14, 2021 · Completed: Jun 30, 2029
1 condition
1 sponsor
19 locations
NCT04847466
Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer
PHASE2
Active, not recruiting
18 participants
Started: Dec 14, 2021 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT05224154
Re-Connect Application for Smoking Cessation
NA
Recruiting
82 participants
Started: Dec 14, 2021 · Completed: Mar 31, 2026
3 conditions
2 sponsors
1 location
NCT04821141
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
PHASE2
Recruiting
120 participants
Started: Dec 14, 2021 · Completed: Jul 31, 2027
2 conditions
2 sponsors
5 locations
NCT05185219
The Effect of Valerian on Insomnia in Menopausal Women
NA
Recruiting
100 participants
Started: Dec 14, 2021 · Completed: Jan 20, 2025
2 conditions
1 sponsor
1 location
NCT04019262
Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
PHASE1/PHASE2
Active, not recruiting
2 participants
Started: Dec 14, 2021 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT04337255
Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet in Stroke Patients Patients
NA
Active, not recruiting
250 participants
Started: Dec 14, 2021 · Completed: May 31, 2027
5 conditions
4 sponsors
1 location
NCT05451108
Pectus Excavatum Camouflage
NA
Active, not recruiting
7 participants
Started: Dec 14, 2021 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05862051
RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer
NA
Recruiting
75 participants
Started: Dec 14, 2021 · Completed: Jun 14, 2025
2 conditions
3 sponsors
9 locations
NCT04975217
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
EARLY_PHASE1
Recruiting
10 participants
Started: Dec 14, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05205811
The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette
PHASE3
Active, not recruiting
180 participants
Started: Dec 14, 2021 · Completed: Oct 20, 2025
1 condition
2 sponsors
2 locations
NCT05046886
Personalized Dietary Management in Type 2 Diabetes
NA
Active, not recruiting
294 participants
Started: Dec 14, 2021 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT04853251
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
PHASE4
Recruiting
188 participants
Started: Dec 14, 2021 · Completed: Apr 30, 2028
1 condition
1 sponsor
50 locations
NCT05075200
Tranexamic Acid Dosing for Major Joint Replacement Surgery
PHASE2
Active, not recruiting
21 participants
Started: Dec 14, 2021 · Completed: Aug 31, 2024
2 conditions
1 sponsor
1 location
NCT04954859
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
PHASE2
Recruiting
450 participants
Started: Dec 14, 2021 · Completed: Feb 8, 2029
1 condition
1 sponsor
51 locations
NCT04980612
Development and Feasibility of Mindfulness Based Pain Reduction
NA
Active, not recruiting
52 participants
Started: Dec 14, 2021 · Completed: Dec 1, 2025
1 condition
2 sponsors
1 location
NCT05136950
Incidence of Glaucoma-related Adverse Events in Pediatric Secondary Intraocular Lens Implantation
NA
Recruiting
228 participants
Started: Dec 14, 2021 · Completed: Jul 30, 2033
1 condition
1 sponsor
1 location
NCT05400174
Blood Pressure Effects on Cognition and Brain Blood Flow in PD
NA
Recruiting
60 participants
Started: Dec 14, 2021 · Completed: Feb 1, 2026
3 conditions
3 sponsors
1 location
NCT05053750
TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
EARLY_PHASE1
Active, not recruiting
14 participants
Started: Dec 14, 2021 · Completed: Feb 2, 2027
3 conditions
3 sponsors
1 location
Previous
1
More pages
1827
1828
1829
1830
1831
1832
1833
More pages
2369
Next